Product Description
Our company has succeeded to achieve respectable position in the market by offering our clients Xovoltib Tablets. These tablets are used for the treatment of patients with metastatic non-small cell lung cancer. Our expert agents source these tablets from the trusted vendors of the market. Before packing in tamper proof materials, these tablets are tested on safety and purity parameters. We offer these Xovoltib Tablets at market leading prices to clients.
Features:
- Slow down the growth of cancer cells
- Block the action of the abnormal protein
- Accurate composition
Precise Targeted Cancer TherapyXovoltib leverages Afatinib Dimaleate to disrupt cancer growth at a molecular level. Its mechanism of action as a tyrosine kinase inhibitor allows for focused intervention in NSCLC. This tailored approach is designed to increase treatment effectiveness while minimizing impact on healthy cells, representing a significant advancement in cancer care.
Convenient Oral AdministrationAdministered as a yellow, film-coated tablet, Xovoltib enables cancer therapy through oral dosing, which improves patient comfort and compliance. The convenient packaging in blister packs within boxes supports safe and controlled dispensing, making daily treatment manageable for those with NSCLC.
Comprehensive Product Safety and StorageXovoltib is dispensed only on an oncologists prescription, ensuring patient safety and adherence to medical guidelines. With clear storage instructionsto keep tablets below 30C and away from moisturethe product is designed for reliability. Its 24-month shelf life makes long-term use feasible for ongoing cancer therapy.
FAQs of Xovoltib Tablets:
Q: How should Xovoltib Tablets be administered for non-small cell lung cancer?
A: Xovoltib Tablets should be taken orally as prescribed by your oncologist, typically once daily. Follow your doctors instructions on timing and dosage to ensure optimal effectiveness in treating NSCLC.
Q: What is the main therapeutic benefit of Xovoltib in cancer treatment?
A: Xovoltib acts as a targeted therapy that inhibits tyrosine kinase activity, specifically interrupting signals that promote growth of cancer cells. This targeted mechanism helps slow or stop the progression of non-small cell lung cancer.
Q: When do I need a prescription for Xovoltib Tablets?
A: Xovoltib is strictly available via prescription and must be dispensed only by retailers on the advice of a registered oncologist, ensuring safe and appropriate use. Self-medication is not permitted with this product.
Q: Where should Xovoltib Tablets be stored to maintain their potency?
A: Store the tablets below 30C and protect them from moisture. Keeping them in their original packaging until use is recommended to ensure quality and stability over the 24-month shelf life.
Q: What is the process for acquiring Xovoltib Tablets in India?
A: You can obtain Xovoltib through authorized distributors, exporters, or traders, but only with a legitimate prescription from a registered oncologist. The product meets regulatory requirements, with documentation such as registration number available upon request.
Q: How do I ensure safe usage of Xovoltib Tablets?
A: Take Xovoltib exactly as directed by your oncologist and follow all provided instructions. Do not alter dosage or discontinue therapy unless instructed by your healthcare professional, and report any unusual side effects promptly.
Q: What makes Xovoltib suitable as a long-term therapy option for NSCLC?
A: With its targeted action, oral convenience, secure blister packaging, and 24-month shelf life, Xovoltib is designed to support ongoing treatment, ensuring reliability and efficacy throughout the course of therapy for NSCLC.